Darmerica, LLC has recalled 1.8 kilograms (approximately 2 units) of Quinacrine Dihydrochloride (98.25%) bulk API product because of a label mix-up. Testing revealed that the product labeled as Quinacrine Dihydrochloride is actually Artemisinin. Consumers who may have received this product should contact their healthcare provider or pharmacist immediately, as the product is not the medication indicated on the label.
The product contains a different active ingredient (Artemisinin) than what is stated on the label (Quinacrine Dihydrochloride). This mix-up could lead to patients receiving the wrong medication, resulting in untreated medical conditions or unexpected side effects from the substituted ingredient.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.